Hepatosplenic T cell lymphoma pathophysiology: Difference between revisions
| Line 36: | Line 36: | ||
* Cases of hepatosplenic T-cell lymphoma have been reported in patients treated with the immunosuppressants [[azathioprine]], [[infliximab]], and [[adalimumab]]. The majority occurred in patients with [[inflammatory bowel disease]]. | * Cases of hepatosplenic T-cell lymphoma have been reported in patients treated with the immunosuppressants [[azathioprine]], [[infliximab]], and [[adalimumab]]. The majority occurred in patients with [[inflammatory bowel disease]]. | ||
==Gross Pathology== | ==Gross Pathology== | ||
* Spleen is enlarged with diffuse involvement of the red pulp without any gross lesions | |||
* Diffuse hepatic enlargement is present as well | |||
==Microscopic Pathology== | ==Microscopic Pathology== | ||
Revision as of 16:09, 24 February 2016
|
Hepatosplenic T cell lymphoma Microchapters |
|
Differentiating Hepatosplenic T cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatosplenic T cell lymphoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma pathophysiology |
|
Directions to Hospitals Treating Hepatosplenic T cell lymphoma |
|
Risk calculators and risk factors for Hepatosplenic T cell lymphoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [4]
Overview
Hepatosplenic T cell lymphoma arises from an immature cytotoxic T-cell clonally expressing the γδ T-cell receptor. Gamma delta (γδ) T cells constitute 1% to 5% of the circulating lymphocytes in human blood. These cells preferentially home in on some epithelial rich tissues and sinusoidal areas of the splenic red pulp where they represent up to 30% of the whole T-cell population. Hepatosplenic γδ T-cell lymphoma (HSTCL) is a rare aggressive subtype of extra nodal lymphoma.
Genetics
- Genes involved in the pathogenesis of hepatosplenic T cell lymphoma include:[1]
- 2-5 copies of i(7)(q10)
- Isochromosome 7q present
- Numerical and structural aberrations of the second chromosome 7
- Rearrangement TRG@, TRB@ genes
- T-cell receptor (TCR) Gamma/Delta genes are clonally rearranged
- Trisomy 8
Immunophenotype[1]
The immunophenotype for hepatosplenic T-cell lymphoma is a post-thymic, immature T-cell.
| Status | Antigens |
| Positive | CD3, TCRδ1, TIA-1, granzyme M, multiple killer immunoglobulin-like receptors (KIR) isoforms |
| Negative | CD4, CD5, CD8, granzyme B, perforin, CD94 |
Association
- Hepatosplenic T cell lymphoma is seen more often in immunosuppressed solid organ transplant recipients.[2]
- Cases of hepatosplenic T-cell lymphoma have been reported in patients treated with the immunosuppressants azathioprine, infliximab, and adalimumab. The majority occurred in patients with inflammatory bowel disease.
Gross Pathology
- Spleen is enlarged with diffuse involvement of the red pulp without any gross lesions
- Diffuse hepatic enlargement is present as well
Microscopic Pathology
The characteristic features of neoplastic cells in hepatosplenic T cell lymphoma include:
-
Peripheral blood smear showing large atypical lymphoid cells with indented nuclei .[6]
-
![A: Bone marrow biopsy showing cellular marrow with diffuse intrasinusoidal and interstitial lymphoid cell infiltrates (Jenner Giemsa, ×100); B: Arrows indicating intrasinusoidal lymphoid cell infiltrate (Jenner Giemsa, ×400).[6]](/images/a/ad/Hepatosplenic_T_cell_lymphoma_bone_marrow_biopsy.jpg)
A: Bone marrow biopsy showing cellular marrow with diffuse intrasinusoidal and interstitial lymphoid cell infiltrates (Jenner Giemsa, ×100); B: Arrows indicating intrasinusoidal lymphoid cell infiltrate (Jenner Giemsa, ×400).[6]
![A: Bone marrow biopsy showing cellular marrow with diffuse intrasinusoidal and interstitial lymphoid cell infiltrates (Jenner Giemsa, ×100); B: Arrows indicating intrasinusoidal lymphoid cell infiltrate (Jenner Giemsa, ×400).[6]](/index.php/File:Hepatosplenic_T_cell_lymphoma_bone_marrow_biopsy.jpg)
| Sites of involvement | Description |
|---|---|
| Spleen and liver |
|
| Bone marrow |
|
| Peripheral blood |
|
References
- ↑ 1.0 1.1 Hepatosplenic T cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52ee/. Accessed on February 22, 2016
- ↑ [1]
- ↑ Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA. "Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen." Am J Clin Pathol. 1994 Sep;102(3):310-5. PMID: 8085554
- ↑ [2]
- ↑ Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT, Craig FE, Vnencak-Jones CL, Gulley ML, Park JP, Cousar JB. "Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas." Am J Surg Pathol. 2001 Mar;25(3):285-96. PMID: 11224598
- ↑ 6.0 6.1 Hepatosplenic gamma delta T-cell lymphoma. Journal of medical case reports. http://www.jmedicalcasereports.com/content/7/1/269. Accessed on February 24, 2016